Mathieu Lupien

Researcher
  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Toronto
Home > About Us > Our People > Researcher Bio
  • Bio

Related Research

  • Breast Cancer

    Deciphering heterogeneity of rare metaplastic breast carcinoma Gold Cohort through spatialomics

    In Canada, less than one per cent of breast cancer patients are diagnosed with metaplastic breast cancer (MpBC), a rare yet highly aggressive form of the disease. Due to its rarity, MpBC has remained...

    Read More
  • Multiple Cancers

    Determinants of stemness that underlie high risk or relapse disease

    There’s an analogy that Dr. John Dick likes to use to describe cancer. For him, cancer is like a weed, with the tumour being the leafy part that sits above ground. The roots, on the other hand, ...

    Read More
  • Completed
    Breast Cancer

    New era of precision medicine in triple-negative breast cancer

    Triple-negative breast cancer (TNBC) persists as a deadly form of breast cancer today that lacks effective therapies. Now, a newly formed and funded Terry Fox Research Institute team hopes to employ a...

    Read More

Related News & Events

  • Research Highlight|November 30, 2020

    Mapping out the mystery of blood stem cells

    Using state-of-the art sequencing technology, Princess Margaret scientists have revealed how stem cells are able to generate new blood cells throughou...

  • Research Highlight|September 01, 2020

    New study reveals mechanisms that drive chemotherapy resistance in aggressive breast cancers

    Targeting breast cancer cells that change and adapt to evade chemotherapy in order to survive and grow, could be a new way to treat the often deadly t...

  • Research Highlight|September 01, 2020

    Developing precision medicine alternatives for triple negative breast cancer

    TFRI-funded scientists in Toronto have made a discovery that could unlock precision medicine treatments for patients diagnosed with triple negative br...

  • Research Highlight|January 14, 2020

    TFRI-funded researchers in Toronto turn 'junk' DNA into gold

    Mining the rich, uncharted territory of the genome or genetic material of a cancer cell has yielded gold for TFRI-funded scientists at the Princess Ma...

  • Research Highlight|October 04, 2019

    Early results from two studies provide insight into who may benefit from immunotherapies

    Two recent studies partly funded by the TFRI are showing results that provide key insights into how immunotherapy works, and who may benefit from it.

  • Press Release|September 07, 2016

    TFRI ANNOUNCES 2016 FUNDING COMPETITION AWARD RECIPIENTS

    Vancouver, BC – Six outstanding Canadian research teams will use $27.3 million in new funding to engineer precision medicines for patients whose cance...

  • All News & Events